Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 1
1(100.0%)
1Total
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00588562Recruiting

Rare Kidney Stone Consortium Patient Registry

Role: collaborator

NCT00588120Phase 1Completed

Enteric Oxalate Absorption Study in Unclassified Hyperoxaluria

Role: collaborator

NCT00589225Completed

Primary Hyperoxaluria Mutation Genotyping

Role: collaborator

NCT00875823Withdrawn

International Registry for Primary Hyperoxaluria

Role: collaborator

All 4 trials loaded